PEAK6 Investments’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$665K Buy
+21,300
New +$530K ﹤0.01% 2146
2023
Q2
Sell
-26,200
Closed -$239K 3985
2023
Q1
$239K Buy
+26,200
New +$335K ﹤0.01% 2978
2022
Q2
Sell
-1,900
Closed -$70K 6128
2022
Q1
$70K Sell
1,900
-1,900
-50% -$74K ﹤0.01% 4442
2021
Q4
$173K Buy
3,800
+1,700
+81% +$88.7K ﹤0.01% 4101
2021
Q3
$133K Sell
2,100
-21,200
-91% -$1.61M ﹤0.01% 4221
2021
Q2
$2.13M Sell
23,300
-27,800
-54% -$2.21M 0.01% 1846
2021
Q1
$3.48M Sell
51,100
-353,200
-87% -$27.4M 0.01% 1354
2020
Q4
$29.3M Buy
404,300
+394,700
+4,111% +$22.9M 0.06% 286
2020
Q3
$364K Buy
9,600
+4,400
+85% +$149K ﹤0.01% 3088
2020
Q2
$184K Sell
5,200
-2,600
-33% -$74K ﹤0.01% 3457
2020
Q1
$170K Buy
+7,800
New +$175K ﹤0.01% 2976
2018
Q4
Sell
-10,000
Closed -$289K 4066
2018
Q3
$289K Buy
+10,000
New +$187K ﹤0.01% 2982

Other funds holding CDNA

PEAK6 Investments's CDNA Position: Q1 2023 in Review

PEAK6 Investments sold out of CareDx (CDNA) in Q1 2023, closing a stake of 6,276 shares — an estimated $80.3K sold.

PEAK6 Investments first reported a position in CDNA in Q3 2018 and held it in 8 quarters. The position peaked at $2.42M in Q4 2021. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • PEAK6 Investments reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • PEAK6 Investments sold 6,276 CareDx shares in Q1 2023, an estimated $80.3K.
  • PEAK6 Investments first reported a position in CareDx in Q3 2018 and held it in 8 quarters.
  • PEAK6 Investments's CareDx position peaked at $2.42M in Q4 2021.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.